Zobrazeno 1 - 10
of 32
pro vyhledávání: '"P. G. Balboni"'
Autor:
Monica Montesi, Anna Tampieri, Alberto Ballardini, Silvia Panseri, Alberta Vandini, P. G. Balboni, Simone Sprio
Publikováno v:
Journal of Biomedical Materials Research Part A. 106:521-530
The present work describes the synthesis and characterization of new apatite phases co-doped with gallium, magnesium and carbonate, exhibiting osteogenic and antibacterial ability. The apatites are synthesized at low temperature to retain nanocrystal
Publikováno v:
Journal of biomedical materials research. Part A. 106(2)
This work describes the synthesis and characterization of new apatite phases co-doped with gallium, magnesium and carbonate, exhibiting osteogenic and antibacterial ability. The apatites are synthesized at low temperature to retain nanocrystallinity
Autor:
Sergio Gianesini, Michele Zuolo, Valentina Gentili, Dario Di Luca, Paolo Zamboni, Elisabetta Caselli, P. G. Balboni, Erica Menegatti, Antonella Rotola
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
The impact of polymicrobial bacterial infection on chronic wounds has been studied extensively, but standard bacteriological analysis is not always sensitive enough. Molecular approaches represent a promising alternative to the standard bacteriologic
Autor:
P. G. Balboni, Antonella Rotola, Enzo Cassai, Alfredo Corallini, Elke Beth-Giraldo, Giuseppe Barbanti-Brodano, Gaetano Giraldo, Monica Pagnani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1061a9e972a1244c610abfd0c32374ca
https://doi.org/10.1159/000415537
https://doi.org/10.1159/000415537
Autor:
Robin Temmerman, Elisabetta Caselli, Sante Mazzacane, Alessio Branchini, Alessia Frabetti, Daniela Platano, Alberta Vandini, Paola Antonioli, P. G. Balboni
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e108598 (2014)
PLoS ONE, Vol 9, Iss 9, p e108598 (2014)
Background Healthcare-Associated Infections (HAIs) are one of the most frequent complications occurring in healthcare facilities. Contaminated environmental surfaces provide an important potential source for transmission of many healthcare-associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7e4ed105b83d5b7d87331cc4a781989
https://hdl.handle.net/11392/2050612
https://hdl.handle.net/11392/2050612
Autor:
P. G. Balboni, Elisabetta Caselli, Francesco Parmeggiani, Rafaela Argnani, Carlo Incorvaia, Roberto Manservigi, Enzo Cassai
Publikováno v:
Vaccine. 19:1225-1231
A secreted form of gB1 (gB1s), previously shown to protect rabbits against HSV-1 ocular infection when inoculated systemically, was delivered to rabbit periocular area to evaluate its vaccine efficacy upon local administration. The efficacy of local
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication
Autor:
Giuseppe Barbanti-Brodano, C Rossi, R Bozzini, P. G. Balboni, Antonella Caputo, Monica Betti, M. P. Grossi
Publikováno v:
Gene Therapy. 4:288-295
A series of retroviral vectors with potential anti-tat and anti- constructs inhibited virus replication at a high multiplicity of rev activity was developed. Vectors containing a tat trans- infection (MOI). At a low MOI, two cell clones containing do
Autor:
Maria Teresa Camerada, Sante Mazzacane, P. G. Balboni, Alberta Vandini, Luca Lanzoni, Maddalena Coccagna, Elisabetta Caselli, Dario Di Luca, Alessio Branchini, Maria D'Accolti, Paola Antonioli
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0148857 (2016)
PLoS ONE, Vol 11, Iss 2, p e0148857 (2016)
Background Contamination of hospital surfaces by clinically-relevant pathogens represents a major concern in healthcare facilities, due to its impact on transmission of healthcare-associated infections (HAIs) and to the growing drug resistance of HAI
Autor:
Rafaela Argnani, M. P. Grossi, Roberto Manservigi, Enzo Cassai, Penelope Mavromara, Silvia Zucchini, Michele Cilli, Vivi Miriagou, P. G. Balboni, Anna Boero, Elisabetta Caselli
Publikováno v:
Vaccine. 23(7)
The guinea pig model of recurrent genital herpes simplex virus type 2 (HSV-2) infection was used to test the immunotherapeutic activity of a glycoprotein subunit vaccine. Vaccine formulation consisted of three recombinant herpes simplex virus (HSV) g